Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)

0.9437 -0.0363 (-3.70%)
Streaming Delayed Price Updated: 11:29 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Citius Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm ↗
 
Via Benzinga
News headline image
3 Reddit Stocks to Buy in May ↗
These trending Reddit stocks have considerable growth catalysts in motion, offering healthy upside potential in May and beyond 
Via InvestorPlace
The Global Cancer immunotherapy market is expected to reach 152 Billion by 2024 led by Astra Zeneca Nasdaq: AZN; Celgene Corp. (NASDAQ: CELG) Including Late Stage Newcomer; Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)
Via Viz Release
News headline image
Citius Pharma Reveals Topline Immunotherapy Data From Late-Stage Lymphoma Trial ↗
 
Via Benzinga
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with... 
Via Benzinga
News headline image
First Patient Dosed in Citius Pharma's Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids ↗
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) announced enrolment of first patient in the Phase 2b clinical study of Halo-Lido for the treatment of hemorrhoids. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6... 
Via Benzinga
News headline image
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of... 
Via Benzinga
News headline image
Penny Stock Watchlist - Here Are My Five Top Picks ↗
If you got into Amazon at the start of 2021, by the end of 2021 you'd have made about 73% gains. Not bad for a year. It's impressive until you consider that one of these stocks made 258% gains in the... 
Via Talk Markets
News headline image
FDA Signs Off Citius Pharma's Phase 2 Trial With Halo-Lido In Hemorrhoids ↗
The FDA has issued a Study May Proceed letter for Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido to treat hemorrhoids. The Company anticipates... 
Via Benzinga
News headline image
Citius Pharmaceuticals: Q1 Earnings Insights ↗
Citius Pharmaceuticals (NASDAQ:CTXR) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Citius... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021 ↗
Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ: 
Via Benzinga
News headline image
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential ↗
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) 
Via Benzinga
News headline image
Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs ↗
Image by falco from Pixabay What happens when the one product keeping you alive becomes infected? Central venous catheters (CVCs) are important life lines for treating many... 
Via Benzinga
News headline image
Could Citius Pharmaceuticals Be a Millionaire-Maker Stock? ↗
A lot would have to go right for this biotech to make investors rich. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5... 
Via Benzinga
News headline image
56 Biggest Movers From Friday ↗
Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70. Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 73.2% to close at $18.79. A 13G... 
Via Benzinga
News headline image
24 Stocks Moving in Friday's Pre-Market Session ↗
Gainers T.A.T. Technologies Ltd. (NASDAQ: TATT) shares rose 53.4% to $9.09 in pre-market trading after the company announced a new MRO partnership with Honeywell. Staffing 360... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (... 
Via Benzinga
Topics Initial Public Offering
News headline image
Mid-Afternoon Market Update: Dow Gains 100 Points; NovoCure Shares Plunge ↗
Toward the end of trading Thursday, the Dow traded up 0.29% to 34,603 while the NASDAQ rose 0.01% to 14,504.68. The S&P also rose, gaining 0.44% to 4,316.39. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today ↗
Another interim analysis has come and gone with an unsatisfying result. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Rises Over 2%; Aligos Therapeutics Shares Slide ↗
Midway through trading Thursday, the Dow traded up 0.20% to 34,571.92 while the NASDAQ fell 0.24% to 14,468.72. The S&P also rose, gaining 0.24% to 4,307.60 The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
30 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per... 
Via Benzinga
Topics Initial Public Offering
News headline image
Mid-Morning Market Update: Markets Open Higher; Walgreens Posts Q3 Profit ↗
Following the market opening Thursday, the Dow traded up 0.18% to 34,565.67 while the NASDAQ rose 0.08% to 14,515.51. The S&P also rose, gaining 0.28% to 4,309.37. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus ↗
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.